Jun 18, 2020

Starpharma to present at OTCQX Virtual Investor Conference

Starpharma to present at OTCQX Virtual Investor Conference

 

Melbourne, Australia; 18 June 2020: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that a pre-recorded presentation by Dr Jackie Fairley, CEO, will be broadcast on Thursday 18 June 2020 (US ET) as part of OTCQX’s Virtual Investor Conference for Global Mid-cap and Large-cap Companies. The conference is primarily attended  by US-based  retail investors, as well as advisors.

Details of the conference are found via www.VirtualInvestorConferences.com. The presentation will feature an overview of Starpharma’s business for new investors, including the Company’s COVID-19 antiviral product and recent highlights from the VivaGel® and DEP® portfolios. The presentation was recorded prior to the DEP® lutetium announcement on 17 June 2020 and will be available on Starpharma’s website. 

The slide presentation is available here (pdf file, 3MB)

Download ASX Announcement: Starpharma to present at OTCQX Virtual Investor Conference (pdf file, 44kb)

 This contains certain forward-looking statements.